Solid Jul 6, 2026
“apoB testing to intensify cholesterol-lowering medication would prevent more heart attacks and strokes than current practice, and that these health benefits were achieved at a cost that represents good value for U.S. healthcare payers”
Ciaran Kohli-Lynch, Northwestern University
Published in JAMA 2026, DOI 10.1001/jama.2026.2986; computer simulation of 250,000 adults. Simulation models require assumptions about uptake and real-world costs; adoption depends on guideline revision.
In the brief: ApoB vs. LDL Cholesterol Testing → Vegetarian News -- ScienceDaily →